Title : Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.

Pub. Date : 2021 Jun

PMID : 33528904






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Reducing the Need for Carbohydrate Counting in Type 1 Diabetes using Closed-Loop Automated Insulin Delivery (Artificial Pancreas) and Empagliflozin: A Randomised Controlled Non-Inferiority Crossover Pilot Trial. Carbohydrates insulin Homo sapiens
2 Use of empagliflozin on the background of automated insulin delivery with carbohydrate counting was associated with lower mean glucose, corresponding to a 14% greater time in target range. Carbohydrates insulin Homo sapiens